CAS 1042672-97-8

IRAK inhibitor 6

CAS: 1042672-97-8

IRAK inhibitor 6

Formula: C₂₀H₂₀N₄O₃S

Purity: ≥98%

Molecular weight: 396.46

Ref: 54-BUP04163

N-[2-Methoxy-4-(4-morpholinyl)phenyl]-2-(3-pyridinyl)-4-thiazolecarboxamide

CAS: 1042672-97-8

Formula: C₂₀H₂₀N₄O₃S

Purity: 98%

Color and Shape: Solid

Molecular weight: 396.4628

Ref: IN-DA008TH1

IRAK inhibitor 6

CAS: 1042672-97-8

IRAK inhibitor 6 is an inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK-4, IC50: 160 nM).

Formula: C₂₀H₂₀N₄O₃S

Purity: 99.44%

Color and Shape: Solid

Molecular weight: 396.46

Ref: TM-T5110

IRAK inhibitor 6

CAS: 1042672-97-8

Purity: ≥98%

Molecular weight: 396.126

Ref: 10-F863234

IRAK inhibitor 6

CAS: 1042672-97-8

IRAK inhibitor 6 is a kinase inhibitor that has been shown to be effective in both pre-clinical and clinical trials for cancer therapy. IRAK inhibitor 6 inhibits the activity of protein kinases, which are enzymes that regulate protein synthesis. This inhibition prevents the phosphorylation of proteins, which is required for their function. The inhibition of protein kinases by IRAK inhibitor 6 results in a decrease in cancer-related genes and an increase in normalizing proteins. In pre-clinical trials, this drug was shown to exhibit low toxicity and significant efficacy against cancers such as prostate cancer, colon cancer, and pancreatic cancer. In clinical trials, it was found to be safe at doses that were up to 10 times higher than the effective dose.

Formula: C₂₀H₂₀N₄O₃S

Purity: Min. 95%

Molecular weight: 396.46 g/mol

Ref: 3D-SRB67297